These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29935952)

  • 1. Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Wanner C; Herzog CA; Turakhia MP;
    Kidney Int; 2018 Aug; 94(2):231-234. PubMed ID: 29935952
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Turakhia MP; Blankestijn PJ; Carrero JJ; Clase CM; Deo R; Herzog CA; Kasner SE; Passman RS; Pecoits-Filho R; Reinecke H; Shroff GR; Zareba W; Cheung M; Wheeler DC; Winkelmayer WC; Wanner C;
    Eur Heart J; 2018 Jun; 39(24):2314-2325. PubMed ID: 29522134
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Edmonston DL; Pun PH
    Kidney Int; 2020 Apr; 97(4):642-644. PubMed ID: 32093916
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
    Herzog CA; Asinger RW; Berger AK; Charytan DM; Díez J; Hart RG; Eckardt KU; Kasiske BL; McCullough PA; Passman RS; DeLoach SS; Pun PH; Ritz E
    Kidney Int; 2011 Sep; 80(6):572-86. PubMed ID: 21750584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
    Levey AS; de Jong PE; Coresh J; El Nahas M; Astor BC; Matsushita K; Gansevoort RT; Kasiske BL; Eckardt KU
    Kidney Int; 2011 Jul; 80(1):17-28. PubMed ID: 21150873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.
    Kelly DM; Ademi Z; Doehner W; Lip GYH; Mark P; Toyoda K; Wong CX; Sarnak M; Cheung M; Herzog CA; Johansen KL; Reinecke H; Sood MM
    Stroke; 2021 Jul; 52(7):e328-e346. PubMed ID: 34078109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac arrhythmias in patients with chronic kidney disease].
    Niehues P; Ellermann C; Eckardt KU; Eckardt L
    Herzschrittmacherther Elektrophysiol; 2019 Sep; 30(3):251-255. PubMed ID: 31338579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).
    Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.
    Ketteler M; Elder GJ; Evenepoel P; Ix JH; Jamal SA; Lafage-Proust MH; Shroff R; Thadhani RI; Tonelli MA; Kasiske BL; Wheeler DC; Leonard MB
    Kidney Int; 2015 Mar; 87(3):502-28. PubMed ID: 25651364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Perkovic V; Agarwal R; Fioretto P; Hemmelgarn BR; Levin A; Thomas MC; Wanner C; Kasiske BL; Wheeler DC; Groop PH;
    Kidney Int; 2016 Dec; 90(6):1175-1183. PubMed ID: 27884312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy.
    Potpara TS; Jokic V; Dagres N; Marin F; Prostran MS; Blomstrom-Lundqvist C; Lip GY
    Curr Med Chem; 2016; 23(19):2070-83. PubMed ID: 26955880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    Odutayo A; Wong CX; Hsiao AJ; Hopewell S; Altman DG; Emdin CA
    BMJ; 2016 Sep; 354():i4482. PubMed ID: 27599725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which anticoagulants should be used for stroke prevention in non-valvular atrial fibrillation and severe chronic kidney disease?
    Kalra PA; Burlacu A; Ferro CJ; Covic A
    Curr Opin Nephrol Hypertens; 2018 Nov; 27(6):420-425. PubMed ID: 30020140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular arrhythmia in chronic kidney disease patients.
    Bonato FOB; Canziani MEF
    J Bras Nefrol; 2017; 39(2):186-195. PubMed ID: 29069243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Existing Risk Scores for Nonvalvular Atrial Fibrillation Useful for Prediction or Risk Adjustment in Patients With Chronic Kidney Disease?
    McAlister FA; Wiebe N; Jun M; Sandhu R; James MT; McMurtry MS; Hemmelgarn BR; Tonelli M
    Can J Cardiol; 2017 Feb; 33(2):243-252. PubMed ID: 27956042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period.
    Wong MC; Kalman JM; Pedagogos E; Toussaint N; Vohra JK; Sparks PB; Sanders P; Kistler PM; Halloran K; Lee G; Joseph SA; Morton JB
    Heart Rhythm; 2015 Oct; 12(10):2047-55. PubMed ID: 26111801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
    Turner S; Onalan O; Bickle B
    CANNT J; 2009; 19(3):29-36; quiz 37-8. PubMed ID: 19899497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care.
    Davison SN; Levin A; Moss AH; Jha V; Brown EA; Brennan F; Murtagh FE; Naicker S; Germain MJ; O'Donoghue DJ; Morton RL; Obrador GT;
    Kidney Int; 2015 Sep; 88(3):447-59. PubMed ID: 25923985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN;
    Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.